Vervaet Benjamin A, Verhulst Anja, Dauwe Simonne E, De Broe Marc E, D'Haese Patrick C
Laboratory of Pathophysiology, Department of Medicine, University of Antwerp, Antwerp, Belgium.
Kidney Int. 2009 Jan;75(1):41-51. doi: 10.1038/ki.2008.450. Epub 2008 Sep 10.
The kidney has several defense mechanisms to avert nephrocalcinosis by preventing intratubular crystal formation and adherence. Little is known about the fate of luminally adhered crystals. In order to study post-crystal adhesion defense mechanisms we quantified the number and morphology of crystal-containing tubules in rats at various time points following ethylene glycol administration as well as in renal biopsies of patients diagnosed with nephrocalcinosis of different etiology. In rats, nephrocalcinosis was completely cleared by epithelial overgrowth of adherent crystals, which were then translocated to the interstitium and subsequently disintegrated. These processes correlated with a low to moderate infiltration of inflammatory cells. Patients with nephrocalcinosis due either to acute phosphate nephropathy, primary hyperoxaluria, preterm birth, or transplantation also showed epithelial crystal overgrowth independent of the underlying disorder or the nature of the crystals. Our study found a quantitative association between changes in tubular and crystalline morphology and crystal clearance, demonstrating the presence of an important and active nephrocalcinosis-clearing mechanism in both rat and man.
肾脏有多种防御机制,可通过防止肾小管内晶体形成和黏附来避免肾钙质沉着症。关于管腔内黏附晶体的转归知之甚少。为了研究晶体黏附后的防御机制,我们在给予乙二醇后的不同时间点,对大鼠含晶体肾小管的数量和形态进行了量化,同时也对诊断为不同病因肾钙质沉着症患者的肾活检组织进行了研究。在大鼠中,黏附晶体的上皮过度生长使肾钙质沉着症完全清除,随后这些晶体转移至间质并分解。这些过程与炎症细胞的低至中度浸润相关。因急性磷酸盐肾病、原发性高草酸尿症、早产或移植导致肾钙质沉着症的患者,也表现出上皮晶体过度生长,这与潜在疾病或晶体性质无关。我们的研究发现肾小管和晶体形态变化与晶体清除之间存在定量关联,表明在大鼠和人类中均存在重要且活跃的肾钙质沉着症清除机制。